fluconazole has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bastiaens, PI; Chandra, A; Hahn, SA; Hoffmann, M; Ismail, S; Papke, B; Triola, G; Vartak, N; Waldmann, H; Wittinghofer, A; Zimmermann, G | 1 |
1 other study(ies) available for fluconazole and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling.
Topics: Adenocarcinoma; Animals; Benzimidazoles; Binding Sites; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 6; Dogs; Humans; Hydrogen Bonding; MAP Kinase Signaling System; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Models, Molecular; Molecular Conformation; Neoplasm Transplantation; Oncogene Protein p21(ras); Protein Binding; Signal Transduction | 2013 |